CJ BIO | IN PRACTICE · BRAZIL
Why Brazilian Feed Producers Are Making the Switch to Granular Tryptophan
Beyond supplying tryptophan, its unique composition offers additional nutritional value, while its granular form brings operational advantages to feed production, including less dust, more accurate dosing, and better mixing uniformity.
Compared with conventional 98% tryptophan, TRP Pro has a higher product inclusion rate to deliver an equivalent amount of L-tryptophan. In production systems equipped for automated weighing, this higher dosing volume can also facilitate automated handling, reducing the need for manual weighing in certain applications.
As CJ BIO introduced TRP Pro as its primary tryptophan solution in Brazil, the first step was to build customer confidence in its performance compared with conventional powdered tryptophan.
Before proceeding with formulation feasibility evaluations, CJ BIO shared in vivo trial results with Brazilian customers, demonstrating comparable or improved performance of TRP Pro versus conventional powdered tryptophan in piglets, broilers, and laying hens.
These findings helped establish a shared understanding of TRP Pro's performance potential, providing a foundation for the next step: evaluating its nutritional and economic feasibility in customers' existing feed formulations.
With confidence in TRP Pro's performance established, the next challenge was to determine how it could fit into customers' existing feed formulations.
Moving from conventional 98% tryptophan to a granulated solution required customers to assess how TRP Pro would perform within their existing nutritional and operational constraints.
CJ BIO supported customers with technical data and a straightforward evaluation process:
This approach enabled customers to assess the feasibility of transitioning from powder to granule using their own formulations, rather than relying solely on product specifications.
Approximately 90% of evaluated customers found TRP Pro technically and economically viable following formulation simulation.
The evaluations showed that TRP Pro could be incorporated while maintaining nutritional specifications and achieving favorable formulation economics.
For premix manufacturers, the higher product inclusion rate initially raised questions about available formulation space. However, simulations generally demonstrated that sufficient space was available while also identifying potential cost advantages.
By evaluating the complete nutritional matrix alongside inclusion rates and formulation economics, customers could make informed decisions about replacing conventional 98% tryptophan with TRP Pro.
With technical and economic feasibility confirmed through formulation simulation, customers were able to move forward with the transition from conventional 98% tryptophan powder to TRP Pro granule.
Supported by CJ BIO's technical expertise and formulation-based evaluation, TRP Pro achieved broad adoption across CJ BIO's Brazilian customer base, becoming its primary tryptophan solution in Brazil.
Successful product transitions start with helping customers overcome barriers to adoption.
The Brazilian case demonstrates CJ BIO's ability to address customer uncertainties through technical expertise and formulation support, turning a promising alternative into a practical, viable solution.